Abbott Laboratories
Finanzas
Cuenta de resultados
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Ebitda | 12.742,0 | 12.380,0 | 10.463,0 |
| EBIT | 7.220,0 | 9.113,0 | 9.204,0 |
| Impuestos | 941,00 | 1.373,0 | 1.140,0 |
| Beneficio neto | 7.071,0 | 6.933,0 | 5.723,0 |
| Beneficio por acción (Importe) | 3,9673 | 3,9389 | 3,2764 |
| Nota: Cifras en millones. | |||
Activo
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Efectivo y equivalentes | 6.896,0 | 9.882,0 | 9.799,0 |
| Cuentas a cobrar | 6.565,0 | 6.218,0 | 6.487,0 |
| Existencias | 6.570,0 | 6.173,0 | 5.157,0 |
| Total activo corriente | 22.670,0 | 25.224,0 | 24.239,0 |
| Inmovilizado | 11.276,0 | 10.278,0 | 10.112,0 |
| Fondo de comercio | 23.679,0 | 22.799,0 | 23.231,0 |
| Otro activo no corriente | 6.289,0 | 5.215,0 | 4.363,0 |
| Activos totales | 73.214,0 | 74.438,0 | 75.196,0 |
| Nota: Cifras en millones. | |||
Pasivo
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Pasivo corriente | 34.387,0 | 37.533,0 | 39.172,0 |
| Deuda a largo plazo | 13.599,0 | 14.522,0 | 17.296,0 |
| Otro pasivo no corriente | 3.466,0 | 3.804,0 | 3.685,0 |
| Fondos propios | 38.603,0 | 36.686,0 | 35.802,0 |
| Deuda neta | 9.002,0 | 7.796,0 | 8.594,0 |
| Nota: Cifras en millones. | |||
Ratios
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Dividendo por acción (Importe) | 1,8200 | 1,9200 | 2,0800 |
| Pay out (%) | 0,4587% | 0,4874% | 0,6348% |
| PER (veces) | 29,802 | 20,888 | 20,287 |
| Valor en libros por acción (Importe) | 20,294 | 21,110 | 22,261 |
| Flujo de caja por acción (Importe) | 5,8876 | 5,4314 | 4,1515 |
| Capitaliación de mercado (Mill.) | 241.364,6 | 191.060,8 | 183.756,0 |
| Empleados | 113.000,0 | 115.000,0 | 114.000,0 |
| Nota: Datos en euros | |||
| Nota: Los datos del año actual y los próximos son estimaciones de S&P Global. | |||